A new artificial intelligence-based software that helps streamline the process of identifying and quantifying amyloid-related imaging abnormalities (ARIA) in patients undergoing treatment for Alzheimer’s disease has just been cleared by the U.S. Food and Drug Administration. Read More

Emerging research suggests that reassessment of breast magnetic resonance imaging (MRI) identified as high-risk by artificial intelligence (AI) may lead to significantly improved detection of early breast cancer. Read More

The Food and Drug Administration (FDA) has granted 510(k) clearance to the Medrad Centargo CT Injection System, which enables contrast administration for multiple patients undergoing computed tomography (CT) exams. Read More

In newly published guidelines, researchers discuss the utility of CT, MRI and PET/CT in the diagnosis, staging, treatment monitoring and follow-up imaging for peritoneal metastases in patients with ovarian or colorectal cancer. Read More

A recent collaboration between Inflo Health and East Alabama Medical Center (EAMC) resulted in substantial improvements in the organisation’s patient follow through, ushering in both increased workflow efficiency and revenue.Read More

New data from Lexis Nexis Risk Solutions—a leading provider of data and analytics—indicates that breast cancer diagnoses among younger women are rising at “troubling” rates. Read More

Artificial intelligence-estimated tumour volume may have more prognostic value than standard risk stratification methods, new research suggests.Read More

Although adverse events related to COVID-19 vaccines are rare, some are life-threatening. Due to the radiologist’s important role in identifying vaccine reactions, it is important that they are familiar with how complications present on imaging.Read More

A newly developed wearable ultrasound device could soon offer a more accurate alternative to electromyography (EMG) and pulmonary function exams.Read More

Researchers at Weill Cornell Medicine just received a grant worth more than $6 million to develop neuroimaging technology that could expand access to Alzheimer’s diagnostics.Read More